Cedars-Sinai Medical Center
Radiation Oncology residency · Los Angeles, CA · Program website
This program's roster hasn't been collected yet, so there's no list of its own faculty and papers. Below is Cedars-Sinai Medical Center's research in radiation oncology, which the program shares with other departments and affiliated hospitals.
About Cedars-Sinai Medical Centerinstitution-wide radiation oncology research
Radiation Oncology publications from Cedars-Sinai Medical Center and affiliated institutions, since 2022. Updated 2026-11-06; refreshed daily.
317
works per year
15th of 47 radiation oncology residency programs
+27.3%
2-year growth
6th of 47 radiation oncology residency programs
26.1%
in top 10% of field (works before 2025)
8th of 47 radiation oncology residency programs
46.8%
cited above world average
12th of 47 radiation oncology residency programs
Works per year · * 2026 so far
Oncology · 831Radiology, Nuclear Medicine and Imaging · 751
Radiation Oncology research topics at Cedars-Sinai Medical Center
Papers in the window; each links to the list on OpenAlex.
- Cardiac Imaging and Diagnostics 555
- Cancer Immunotherapy and Biomarkers 205
- Pancreatic and Hepatic Oncology Research 104
- Cutaneous Melanoma Detection and Management 70
- CAR-T cell therapy research 64
- Advanced MRI Techniques and Applications 62
- Cancer survivorship and care 61
- Radiomics and Machine Learning in Medical Imaging 30
Most cited at Cedars-Sinai Medical Center since 2024
All radiation oncology papers there on OpenAlex
- Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b studyJeffrey S. Weber et al. · The Lancet · 2024 · PubMed · cited 958
- CAR-macrophage therapy for HER2-overexpressing advanced solid tumors: a phase 1 trialKim A. Reiss et al. · Nature Medicine · 2025 · PubMed · cited 270
- Cutaneous melanoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upTeresa Maria Santos Amaral et al. · Annals of Oncology · 2024 · PubMed · cited 232
- Single-cell and spatial profiling identify three response trajectories to pembrolizumab and radiation therapy in triple negative breast cancerStephen Lawrence Shiao et al. · Cancer Cell · 2024 · PubMed · cited 212
- Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic CancerEileen Mary O'Reilly et al. · New England Journal of Medicine · 2026 · PubMed · cited 166
- Epidemiology of gastrointestinal cancers: a systematic analysis from the Global Burden of Disease Study 2021Pojsakorn Danpanichkul et al. · Gut · 2024 · PubMed · cited 165
- Botensilimab plus balstilimab in relapsed/refractory microsatellite stable metastatic colorectal cancer: a phase 1 trialAndrea J. Bullock et al. · Nature Medicine · 2024 · PubMed · cited 159
- Standards for quantitative assessments by coronary computed tomography angiography (CCTA)Koen Nieman et al. · Journal of cardiovascular computed tomography · 2024 · PubMed · cited 135
- Pembrolizumab versus ipilimumab for advanced melanoma: 10-year follow-up of the phase III KEYNOTE-006 studyGeorgina Venetia Long et al. · Annals of Oncology · 2024 · PubMed · cited 131
- Autogene cevumeran with or without atezolizumab in advanced solid tumors: a phase 1 trialJuanita Suzanne Lopez et al. · Nature Medicine · 2025 · PubMed · cited 129